ReviewTranslational oncology2026

MET-Aberrant non-small cell lung cancer: from kinase dependence to cell-surface targetability-mechanistic basis and biomarker framework for bispecific antibodies and antibody-drug conjugates.

Haoyu Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.